Use of asprosin and subfatin for differential diagnosis of serous ovarian tumors

ArticleAçık Erişim

Özet

Asprosin (ASP) and subfatin are hormones that regulate glucose metabolism. The role of ASP and subfatin in serous ovarian tumors has not been investigated. We investigated the expression of subfatin and asprosin in 30 serous benign, 30 serous borderline, 30 malignant and 30 control ovarian tissues. We investigated ASP and subfatin immunoreactivity and quantification was achieved using an ELISA method. ASP and subfatin were localized in the epithelial parts of normal ovarian tissues; however, in cancer tissues, immunoreactivity was detected in the parenchymal areas. Biochemical analysis of ovarian tissues revealed significantly decreased ASP and subfatin compared to the control. We propose that ASP and subfatin are promising candidates for biomarkers to distinguish serous benign, serous borderline and malignant ovarian cancers. © 2022 The Biological Stain Commission.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12480Resmi atıflarda kullanılan kalıcı adres
Tam Kayıt
AlanDeğerDil
dc.contributor.authorMirzaoglu, Miyase
dc.contributor.authorYavuzkir, Seyda
dc.contributor.authorMirzaoglu, Cetin
dc.contributor.authorYurt, Nurdan
dc.contributor.authorDagli, Adile Ferda
dc.contributor.authorOzcan Yildirim, Sena
dc.contributor.authorSahin, İbrahim
dc.contributor.authorAydin, Suleyman
dc.date.accessioned2026-10-18T20:27:22.735132364Z
dc.date.available2026-10-18T20:27:22.735132364Z
dc.date.issued2023
dc.description.abstractAsprosin (ASP) and subfatin are hormones that regulate glucose metabolism. The role of ASP and subfatin in serous ovarian tumors has not been investigated. We investigated the expression of subfatin and asprosin in 30 serous benign, 30 serous borderline, 30 malignant and 30 control ovarian tissues. We investigated ASP and subfatin immunoreactivity and quantification was achieved using an ELISA method. ASP and subfatin were localized in the epithelial parts of normal ovarian tissues; however, in cancer tissues, immunoreactivity was detected in the parenchymal areas. Biochemical analysis of ovarian tissues revealed significantly decreased ASP and subfatin compared to the control. We propose that ASP and subfatin are promising candidates for biomarkers to distinguish serous benign, serous borderline and malignant ovarian cancers. © 2022 The Biological Stain Commission.
dc.description.sponsorshipWe thank the Scientific Research and Support Unit of Firat University for their financial support for the conduct of the study with the protocol number TF.19.29.
dc.identifier.doi10.1080/10520295.2022.2135763
dc.identifier.eissn1473-7760
dc.identifier.endpage146
dc.identifier.issn1052-0295
dc.identifier.issue2
dc.identifier.pmid36281766
dc.identifier.scopus2-s2.0-85141192470
dc.identifier.startpage140
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12480
dc.identifier.volume98
dc.identifier.wosWOS:000871800200001
dc.language.isoen
dc.publisherTaylor and Francis Ltd.
dc.relation.ispartofBiotechnic and Histochemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAsprosin
dc.subjectmeteorin-like protein
dc.subjectmetrnl
dc.subjectserous ovarian cancer
dc.subjectsubfatin
dc.subjectBiomarkers, Tumor
dc.subjectDiagnosis, Differential
dc.subjectFemale
dc.subjectHumans
dc.subjectOvarian Neoplasms
dc.subjecttumor marker
dc.subjectdifferential diagnosis
dc.subjecthuman
dc.subjectmetabolism
dc.subjectovary tumor
dc.titleUse of asprosin and subfatin for differential diagnosis of serous ovarian tumors
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus10
rdl.citation.wos11
rdl.departmentDepartment of Medical Biology, Medical School, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)